Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.
This overexpression causes an age-dependent accumulation of Aβ plaques that are quantitatively and qualitatively similar to those of the AD brain, but does not reproduce the complete phenotype ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
News-Medical.Net on MSN2d
Experimental drug shows promise in reducing risk of Alzheimer's-related dementiaAn experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...
A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain ...
Asian News International on MSN1d
Anti-amyloid drug displays signs of preventing Alzheimer's dementia: StudyA new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback